Bar et al. found the activating transcription factor 3 (ATF3) as an important regulator of cisplatin cytotoxicity, being activated in platin-sensitive lung cancer cells due to cisplatin treatment [39]. This evidence concerns the gene ATF3 and lung carcinoma.